Latest in Finance

Arterex completes acquisition of medical device manufacturer Phoenix

The medical device specialist will have access to Phoenix's Modena facility, which has four ISO 8 cleanrooms for sterile assembly and packaging and 37,000 sqft of manufacturing space

Find out more

Siemens named a manufacturing execution systems leader by IDC MarketScape

The MES provider's Opcenter won Siemens this title, as it can assist small to medium manufacturers in effectively co-ordinating their shop floor processes and supply chain
See more

Cormica acquires laboratory services provider Zwisler Laboratorium

This acquisition will expand Cormica's European footprint, allowing it to serve biotech and pharmaceutical clients in the key German market

ReciBioPharm attains Bill & Melinda Gates Foundation grant to achieve continuous RNA manufacturing

The biologics CDMO hopes to bring RNA medicines to more patients globally by providing its xRNA continuous manufacturing technology to lower and middle income countries

Moderna bags $590m US investment to accelerate mRNA-based bird flu vaccine development

The pharmaceutical company's investigational influenza vaccine targets the H5 and H7 varieties, and is currently being prepared for Phase III trials

Kindeva Drug Delivery to supply nerve agent antidote autoinjector to the US SNS

The CDMO will produce the DuoDote autoinjecter containing atropine and pralidoxime chloride at its fill/finish manufacturing facility in St Louis, Missouri

Aragen obtains $100m investment from Quandria Capital to drive growth in the small molecule and biologic sectors

The pharmaceutical CRDMO will now focus on expanding its infrastructure and capabilities in the US and Europe

Johnson & Johnson to bolster neuroscience portfolio with $14.6bn Intra-Cellular Therapies acquisition

Through this potential acquisition, Johnson & Johnson will add schizophrenia and bipolar drug Caplyta to its portfolio, as well as a range of clinical candidates designed to treat neurological diseases

etherna and Dropshot team up to optimise the RNA drug development process in $950m deal

The two companies will combine their LNP and mRNA-based technologies to develop precision medicines for cardiac and renal diseases

The new F-Gas Regulation and its impact on pharmaceutical freeze-drying

Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex, integrated system that balances both technical and biological specifications with economic, safety, and environmental concerns

Latest posts in Finance

Merck buys WuXi Biologics' Irish vaccine manufacturing facility for $500m

This sale is part of WuXi Biologics' initiative to build business in the face of the BIOSECURE act, as the company places a stronger focus on building its CDMO services in China

Neuraxpharm bolsters its CNS-targeting therapeutic range with narcolepsy drugs Nuvigil and Provigil

By acquiring Teva Pharmaceutical's Nuvigil and Provigil, Neuraxpharm hopes to enhance its narcolepsy offering, while also expanding its global presence

HOOKIPA Pharma begins non-binding discussions to acquire Poolbeg Pharma

The two pharmaceutical companies may create a clinical-stage biopharmaceutical company focused on the development and commercialisation of next-generation immunotherapies

Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China

New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region

Newcells Biotech raises additional funding from investors

Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance

ACG expands global footprint with new capsule manufacturing facility in Thailand

New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets

Novo Holdings completes acquisition of Catalent

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
You need to be a subscriber to read this article.
Click here to find out more.

Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535

Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist

£20m Scottish oligonucleotide manufacturing innovation centre now under construction

The centre will act as an innovation centre, assisting in the development and optimisation of oligonucleotide manufacturing processes, while also bolstering the UK's biopharmaceutical presence

Novo Nordisk invests DKK 8.5bn into new Danish modular production site

This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within rare disease indications

Gerresheimer acquires Bormioli Pharma Group through Blitz LuxCo Sarl merger

Gerresheimer and Bormioli Pharma will merge to provide the biotech and pharmaceutical industries with primary packaging solutions, dosing systems, closure solutions and accessories

Amgen invests $1bn into new US drug manufacturing facility

The site will be the CDMO's second drug substance manufacturing facility in North Carolina, and will boost its presence in the US pharmaceutical market

Sponsor content

Vetter strengthens senior management team for growth

Three new managing directors to support global sustainable development

Piramal Pharma Limited reports robust growth in CDMO and sustainability initiatives

US$80 million Lexington expansion to double sterile fill-finish capacity

Piramal Pharma releases Q2 results for FY2025

The company's CDMO business is driving its growth significantly, with a 17% increase YoY

Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx

The acquisition strengthens Actylis’ presence in the VMS and OTC markets

Ansell acquires Kimberley-Clark's personal protective equipment business

The novel acquisition will bolster Ansell's PPE offerings for customers in the laboratory and cleanroom environments

Medical devices spur growth for ByteSnap Design

Electronics design company employees boosted to 43 as a result of rapid expansion

Cumulus Oncology raises £9m in seed financing

Proceeds from the financing will be used to support Cumulus Oncology’s future growth plans, expand its portfolio and accelerate the development of new cancer treatments...

ADC Therapeutics regains compliance with NYSE continued listing standards

ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs)

SGS joins forces with Agilex Biolabs

This collaboration marks a significant step in strengthening SGS’s global footprint in the bioanalysis services sector

CPHI Barcelona Snapshot: CordenPharma

At CPHI Barcelona, Dr Kevin Robinson talked to Dr Michael Quirmbach, CEO and President of CordenPharma, about the company’s recent activities and what lies ahead

Glox Therapeutics secures £4.3m seed funding to develop precision antimicrobials

Investment to accelerate development of a novel class of targeted high-potency bacteriocins against specific antimicrobial-resistant pathogens

AtkinsRéalis awarded engineering design services contract for API manufacturing facility in Singapore

When completed, the Singapore site will play a critical role in WuXi AppTec’s global network across Asia, Europe and North America, meeting the growing demand from...